Insulet | PODD

Stock Price
348.43
Daily Change
1.96 0.57%
Monthly
25.65%
Yearly
62.25%
Q3 Forecast
336.18

Peers Price Chg Day Year Date
Abbott 132.94 0.13 0.10% 16.68% Sep/05
Align Technology 139.09 4.39 3.26% -37.10% Sep/05
AtriCure 35.38 -0.28 -0.79% 34.83% Sep/05
Avanos Medical 12.72 0.06 0.47% -46.37% Sep/05
Baxter International 24.42 0.84 3.56% -37.34% Sep/05
Becton, Dickinson and Co. 192.39 1.13 0.59% -17.28% Sep/05
Boston Scientific 107.22 -0.07 -0.07% 31.36% Sep/05
Cardinal Health 149.56 0.22 0.15% 33.55% Sep/05
Cooper Companies 68.08 0.08 0.12% -36.14% Sep/05
Dexcom 80.54 -0.22 -0.27% 17.15% Sep/05
Edwards Lifesciences 80.94 -0.02 -0.02% 21.19% Sep/05
Globus Medical 60.60 0.31 0.51% -13.42% Sep/05
Integra LifeSciences 15.99 0.34 2.17% -13.57% Sep/05
ICU Medical 131.24 5.61 4.47% -19.15% Sep/05
J&J 178.38 -0.38 -0.21% 8.48% Sep/05
Eli Lilly 727.21 -15.70 -2.11% -19.48% Sep/05
Masimo 147.19 4.18 2.92% 31.97% Sep/05
Medtronic 92.93 0.13 0.14% 3.32% Sep/05
Merit Medical Systems 92.97 0.82 0.89% -3.74% Sep/05
Insulet 348.43 1.96 0.57% 62.25% Sep/05
Roche Holding 274.20 -1.50 -0.54% 0% Sep/05
Solventum Corp 72.72 0.34 0.47% 9.85% Sep/05
Stryker 392.31 -2.03 -0.51% 9.17% Sep/05
Teleflex 130.70 1.61 1.25% -46.61% Sep/05
Tandem Diabetes Care 12.58 0.19 1.53% -70.33% Sep/05
West Pharmaceutical Services 250.73 3.19 1.29% -15.66% Sep/05
Zimmer Biomet Holdings 105.73 0.97 0.93% 0.76% Sep/05

Indexes Price Day Year Date
USND 21700 -7.31 -0.03% 30.01% Sep/05
US2000 2389 9.14 0.38% 14.22% Sep/05
US500 6481 -20.59 -0.32% 19.84% Sep/05

Insulet traded at $348.43 this Friday September 5th, increasing $1.96 or 0.57 percent since the previous trading session. Looking back, over the last four weeks, Insulet gained 25.65 percent. Over the last 12 months, its price rose by 62.25 percent. Looking ahead, we forecast Insulet to be priced at 336.18 by the end of this quarter and at 325.30 in one year, according to Trading Economics global macro models projections and analysts expectations.

Insulet Corporation is primarily engaged in the development, manufacture and sale of its proprietary Omnipod System, a continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod Insulin Management System (Omnipod), the Omnipod DASHTM Insulin Management System (Omnipod DASH) and its digital mobile Omnipod platform. The Omnipod System features two devices: a small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod) and a Personal Diabetes Manager (PDM). Users has to fill the Pod with insulin and wear directly on the body. It can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh or lower back. The Pod delivers precise, personalized doses of insulin into the body through a small flexible tube, cannula. PDM is a wireless, handheld device that programs the Pod with the user’s personalized insulin-delivery instructions and wirelessly monitors the Pod’s operation.